AGN-193408

N/A

Report date: 2024/11/26 14:38:33
NME

Base Information

Drug NameAGN-193408
Drug Alias NameAGN-193408 sustained-release implantAGN-193408 implantAGN 193408 sustained-releaseAGN-193408AGN-193408 SR +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor modulators
TargetsProstanoid FP receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A